ZUMA-2
Gilead Sciences
Gilead Sciences
National Institutes of Health Clinical Center (CC)
Allogene Therapeutics
Intima Bioscience, Inc.
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Institute of Hematology & Blood Diseases Hospital, China
Juno Therapeutics, a Subsidiary of Celgene
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Zhejiang Provincial People's Hospital
Xinqiao Hospital of Chongqing
Ohio State University Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Gilead Sciences
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Goethe University
Thomas Jefferson University
Fate Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Astellas Pharma Inc
Case Comprehensive Cancer Center
Gilead Sciences
French Innovative Leukemia Organisation
Gilead Sciences
Therapeutic Advances in Childhood Leukemia Consortium
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Stanford University
National Institutes of Health Clinical Center (CC)
Janssen Scientific Affairs, LLC
Thomas Jefferson University
University of Liverpool
Vanderbilt-Ingram Cancer Center
Memorial Sloan Kettering Cancer Center
The Netherlands Cancer Institute
Fred Hutchinson Cancer Center
Baylor College of Medicine
Centre Hospitalier Universitaire Vaudois
Immatics US, Inc.
M.D. Anderson Cancer Center
German CLL Study Group